Opportunity
Simpler Grants.gov #FOR-FD-25-004
FDA Cooperative Agreement: Center for Research on Complex Generics
Posted
August 15, 2024
Identifier
FOR-FD-25-004
NAICS
541715
The Food and Drug Administration (FDA) is offering a cooperative agreement to establish a Center for Research on Complex Generics. - Government Buyer: - Food and Drug Administration (FDA) - Purpose and Scope: - Fund the creation and operation of a Center for Research on Complex Generics - Support FDA's mission to improve access to high-quality, safe, and effective generic drugs - Facilitate collaboration with the generic drug industry, academia, and other stakeholders - Conduct and coordinate research projects focused on complex generic products - Host scientific workshops, provide training, and support educational activities - Ensure free and open public access to research outcomes - Products/Services Requested: - Establishment and operation of a research center (no specific products, part numbers, or OEMs required) - Unique Requirements: - Center must engage with industry and academic representatives - Must provide public access to research results - Eligible applicants include government, educational, nonprofit, and business entities - Estimated Award: - $1,500,000 for one recipient - No specific OEMs or vendors are named, as this is a grant for research center establishment, not a product procurement.
Description
The FDA seeks to fund a Center for Research on Complex Generics through a cooperative agreement. The center will support FDA's efforts to enhance collaborations with the generic drug industry, focusing on research, engagement, and education related to generic drugs, especially complex generics. It aims to facilitate stakeholder collaboration, conduct research projects, host workshops, and provide public access to research outcomes.